Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas.
暂无分享,去创建一个
H. Aburatani | S. Kōzuma | Y. Taketani | H. Kuramoto | F. McCormick | Y. Ikeda | S. Nakagawa | K. Oda | T. Yano | K. Kawana | Y. Ikeda | O. Wada-Hiraike | M. Nishida | T. Kashiyama | Kumi Shoji | Y. Miyamoto | M. Tanikawa | O. Hiraike-Wada | K. Sone | A. Miyasaka | Y. Matsumoto | H. Hiraike | K. Shoji | Takahiro Koso | T Kashiyama | M Tanikawa | H Kuramoto | O Hiraike-Wada | S Kozuma | H. Kuramoto